In patients with Acute Myeloid Leukemia (AML). the assessment of disease risk plays a central role in the era of personalized medicine. Indeed. integrating baseline clinical and biological features on a case-by-case basis is not only essential to select which treatment would likely result in a higher probability of achieving complete remission. https://thegreensjunglebeautyshops.shop/product-category/perfume/